1. Introduction
===============

Schistosomiasis japonica, caused by *Schistosoma japonicum*, is known to have several clinical stages of disease which are a direct result of an immunopathological reaction to the deposition of eggs in vital organs of the host, particularly the liver and spleen. The eggs initiate the onset of acute infection characterised by non-specific symptoms including fever and eosinophilia and in some cases hepato-splenic inflammation and mild forms of diffuse fibrosis ([@bib40]). Long-term effects of infection or repeated re-infection and subsequent accumulation of the egg-induced granuloma in the liver can be observed in chronic and, more predominantly, advanced patients. The latter typically display signs of severe liver damage, a result of large collagen deposits in the periportal spaces leading to portal hypertension, splenomegaly, shunting and gastrointestinal varices ([@bib39; @bib18]).

Granuloma formation is controlled and modulated by several cell types and protein interactions, primarily CD4+ T-cells, Th1 cytokines and cell adhesion factors ([@bib46; @bib22; @bib43]). Intracellular adhesion molecule 1 (ICAM-1) is present on endothelial cells, antigen presenting cells and fibroblasts and belongs to the immunoglobulin superfamily of proteins ([@bib42; @bib22; @bib47]). It is well established that the Th1 cytokines, IFN-gamma and TNF-alpha, both trigger the release of soluble ICAM-1 (sICAM-1) ([@bib32; @bib35; @bib29]) and are known to play key roles in the modulation ([@bib10; @bib5]) and aggravation of hepatic fibrosis ([@bib21; @bib6]), respectively. The soluble form of ICAM-1 is involved in lymphocyte and eosinophil recruitment and inflammatory, immune-mediated mechanisms ([@bib28; @bib36; @bib17]). Raised levels of sICAM-1 have been observed in the serum of patients with acute and chronic liver disorders ([@bib1]). Elevated expression has also been associated with intestinal schistosome infection and early granuloma formation in murine studies ([@bib37; @bib38; @bib13; @bib20]). sICAM-1 also plays a role in modulation of the schistosome granuloma ([@bib22]). Further, the granulomatous response is mediated by eosinophils, the recruitment of which is critically dependent on ICAM-1 ([@bib45; @bib17]). Human studies have also noted a significant increase in sICAM-1 levels in serum and plasma of hepatic schistosomiasis patients ([@bib41; @bib14; @bib34]).

TNF-alpha is thought to aggravate hepatic fibrosis caused by *Schistosoma mansoni* ([@bib21; @bib6]). TNF-alpha initiates shedding of the membrane receptors TNFR-I and II which are cleaved from the membrane and are detectable in serum, plasma and urine ([@bib15; @bib16; @bib11]). Given this relationship, levels of soluble TNFRs (sTNFRs) could reflect TNF-alpha activity. As receptor levels remain elevated longer than TNF-alpha, they have shown potential as markers of disease progression in human schistosomiasis ([@bib34]) and have been implicated in schistosome oviposition and circumoval granuloma formation in murine studies ([@bib19]).

Immunoglobulins IgG and subclass IgG4 have been shown to have a pivotal role in the humoral response to schistosomal infection. A few studies have reported that measurement of these antibodies can be used to differentiate between different disease stages, in particular acute and chronic patients ([@bib26; @bib4]). High levels of IgG4 have also been associated with periportal fibrosis and portal hypertension in patients with advanced schistosomiasis mansoni ([@bib44]).

Here, we report on the serum levels of sICAM-1, sTNFR-I and sTNFR-II in patients with different clinically defined stages of schistosomiasis japonica as the basis for investigating their role in schistosome-induced human hepatic disease. In addition, total IgG and IgG4 levels were assessed to investigate their potential in the differential diagnosis of disease stage.

2. Materials and methods
========================

2.1. Study patients
-------------------

The study involved 127 participants from endemic areas of the Poyang and Dongting lakes in Jiangxi and Hunan provinces, China, respectively, with different clinical stages of schistosomiasis ([Table 1](#tbl1){ref-type="table"}), defined according to the guidelines established by the Ministry of Public Health in China ([@bib8; @bib33]).

Thirty-five subjects were diagnosed with acute disease. These individuals had all tested egg-positive after stool examination using the Kato-Katz ([@bib25]) thick smear technique, by serology using indirect haemagluttination and ELISA assays with soluble egg antigen (SEA) and soluble worm adult protein (SWAP) ([@bib33]). They also had a clear history of recent water contact and presented clinical symptoms associated with acute infection including fever, cough, bloody diarrhoea and eosinophilia (⩾15% of their total leukocyte count). Forty-five patients with chronic schistosome infections also participated in the study. They were defined as individuals who were found to be infected with *S. japonicum* by faecal examination ([@bib25]) during a population survey. They had a history of water contact and *S. japonicum* infection but were asymptomatic with no clinical features of disease. Advanced patients (*N* = 34) were diagnosed if they presented with splenomegaly (Hackett degree ⩾ II) (WHO, 2000. Ultrasound in schistosomiasis: A practical guide to the standardised use of ultrasonography for the assessment of schistosomiasis-related morbidity. In: Richter, J., Hatz, C., Campagne, G., Bergquist, N.R., Jenkins, J.M. (Ed). Second International Workshop, Niamey, Niger), hypersplenism and portal hypertension.

In addition, 20 subjects from non-endemic areas with no known history of exposure to infection or liver disease were recruited during routine health checks at a local clinic in Yueyang, Hunan province. All control subjects tested negative for *S. japonicum* infection using the Kato-Katz thick smear technique ([@bib25]).

2.2. Serum processing
---------------------

Venous blood samples (4--5 ml) were obtained from all subjects with informed consent. Sera were separated within 12 h of collection, using standard procedures and stored at −80 °C. Aliquots of all serum samples were then transported on dry ice to the Queensland Institute of Medical Research, Brisbane and stored at −80 °C until analysed. An additional 0.5 ml of blood was collected into EDTA tubes. Twenty microlitres of the blood was mixed with 380 μl eosin--acetone solution and incubated at room temperature for 5--10 min. Eosinophils were counted using a haemocytometer under a light microscope.

2.3. Soluble receptor assays
----------------------------

Commercially available ELISA kits were used to measure serum levels of sTNFR-I, sTNFR-II and sICAM-1 (R&D Systems, Inc., Minneapolis). ELISAs were carried out according to the manufacturer's instructions and all serum samples were measured in duplicate. Sample dilutions were 1:25, 1:100 and 1:800 for TNFR-I, TNFR-II and sICAM-1, respectively. Concentrations for each soluble protein marker were determined from a serial-fold diluted standard. The minimum levels of detection for each assay were 6.25 pg/ml, 3.91 pg/ml and 7.81 pg/ml for TNFR-I, TNFR-II and sICAM-1, respectively.

2.4. Immunoglobulin assays
--------------------------

SEA and SWAP were prepared as described previously ([@bib30]); antigen-specific IgG4 and total IgG levels were measured by indirect ELISA. Briefly, ELISA plates (Nunc, Inc., Naperville) were coated with 5 μg/ml SEA or 10 μg/ml SWAP in 50 mM carbonate buffer (pH 9.6) and incubated overnight at 4 °C. Plates were washed three times with PBS (pH 7.6) containing 0.05% Tween 20^®^ and blocked using a PBS solution containing 1% BSA for 1 h at room temperature. After a further three washes, primary human serum samples were plated in duplicate in 1:100 and 1:200 dilutions for detection of IgG4 and total IgG, respectively, and again incubated at room temperature for 1 h. The plates were washed a further three times and incubated for 1 h at room temperature with Streptavidin--horseradish peroxidase (HRP)-labelled detection antibodies in dilutions of 1:400 for IgG4 (Zymed, Inc., San Francisco) and 1:100,000 for total IgG (Bethyl, Inc. Montgomery), respectively. After a final three washes, the detection reaction was developed using 3,3,5,5-tetramethylbenzidine (TMB) peroxidase substrate solution. After 30 min, the developed colour was stopped with 2 M H~2~SO~4~ and the OD was measured at 450 nm using a Bio-Rad^®^ ELISA reader. A blank PBS control was used on each plate and the OD values were adjusted for plate-to-plate variation by means of a positive internal standard.

2.5. Statistical analysis
-------------------------

All data were analysed using SPSS 13.0. Analysis-of-variance (ANOVA) was used to evaluate the overall significance between groups. Games--Howell post hoc tests were performed to assess the pair-wise differences in protein marker levels and immunoglobulin levels between the different clinically defined groups and multivariate nominal regression was used to estimate the strength of association for each soluble protein marker. Results are expressed as mean ng/ml for soluble protein markers and 95% confidence intervals (CIs) for each group. Antigen-specific IgG4 and total IgG results are expressed as ODs. A log transformation was applied to egg count data to normalise the distribution and was used as a measure of infection intensity (LnEPG). Correlations between markers and between LnEPG and eosinophil counts were analysed using the Pearson correlation coefficient. All figures display median protein marker or immunoglobulin levels for each clinical disease group.

2.6. Ethical considerations
---------------------------

Informed consent was obtained from all participants prior to blood collection. All patients who were stool-egg positive were offered a single dose of praziquantel at the recommended Word Health Organization (WHO) level (40 mg/kg). They were subsequently re-tested to ensure the infection was cleared. Ethical clearance for the study was obtained from the Medical Ethics Committee of Hunan Province and Queensland Institute of Medical Research.

3. Results
==========

3.1. Soluble TNF receptors and ICAM-1 levels in the different clinically defined disease groups
-----------------------------------------------------------------------------------------------

Elevated levels of sTNFR-I, sTNFR-II and sICAM-1 were observed in all clinically defined schistosomiasis groups compared with the control group ([Fig. 1](#fig1){ref-type="fig"}). Post hoc tests were used to identify significant differences between the means for each marker between each clinical disease group. The increase observed in chronically infected patients compared with the control group was not significant for any of the three protein markers (*P* = 0.0567; *P* = 0.0638 and *P* = 0.6996, respectively). Significantly higher mean levels of TNFR-I, sTNFR-II but not sICAM-1 were observed in advanced patients compared with controls (*P* = 0.0314; *P* = 0.00296; *P* = 0.1156, respectively). Acute patients demonstrated the highest levels of all three markers which were significantly higher than the control group (*P* = 0.0427; *P* \< 0.000001; *P* = 0.00011, respectively) and significantly higher sTNFR-II levels were observed compared with advanced patients (*P* = 0.00008) and chronic patients (*P* \< 0.000001). To identify markers most associated with disease, multivariate nominal regression was carried out. Likelihood ratio tests identified sTNFR-I to be a non-significant predictor of disease and it was subsequently omitted from the final model. The regression analysis showed sTNFR-II and sICAM-1 to both be significantly associated with acute infection in the presence of the other (*P* = 0.0001 and *P* = 0.0156, respectively). sTNFR-II showed the largest strength of association with disease (OR = 1.099; 95% CI = 1.047--1.154). Both markers were not significant for any other disease stage.

3.2. Soluble protein correlations, infection intensity and eosinophil counts
----------------------------------------------------------------------------

The Pearson correlation coefficient was used to estimate bi-variate correlations between the protein markers, infection intensity and eosinophil counts. All markers showed significant positive correlations with each other ([Table 2](#tbl2){ref-type="table"}), with sTNFR-I and sTNFR-II showing the highest correlation (Pearson correlation = 0.723; *P* \< 0.00001) thus demonstrating a linear relationship between the two.

In the acute schistosomiasis group, highly significant positive correlations were found between eosinophil count and infection intensity (Pearson correlation = 0.477; *P* = 0.0072), and eosinophil count and the level of sICAM-1 (Pearson correlation = 0.363; *P* = 0.0014).

3.3. Immunoglobulin levels in the different clinically defined disease groups
-----------------------------------------------------------------------------

ANOVA post hoc tests showed all SEA- and SWAP-specific total IgG and SEA-specific IgG4 levels were significantly higher in the acute, chronic and advanced groups compared with controls ([Fig. 2](#fig2){ref-type="fig"}). Antigen-specific immunoglobulin levels in acute and chronic patient groups were not significantly different from each other. SEA-specific total IgG measurements were significantly lower in advanced patients than in the acute and chronic disease groups (*P* \< 0.00001; *P* \< 0.00001, respectively) as were SWAP-specific total IgG levels (*P* = 0.0067; *P* = 0.0033, respectively). Though antigen-specific IgG4 levels were higher in acute and chronic patients than in the advanced patients ([Fig. 2](#fig2){ref-type="fig"}), there was no significant difference in SWAP-specific IgG4 between acute and advanced patients (*P* = 0.0643). The mean level of SWAP-specific IgG4 observed in advanced patients compared with controls was also not significant (*P* = 0.0891).

4. Discussion
=============

Hepatic schistosomiasis is characterised by hepato-splenic inflammation due to an immunopathological reaction to deposition of schistosome eggs in the liver. The eggs cause an immune reaction mediated by eosinophils and macrophages and induce a delayed-type hypersensitivity response, resulting in granuloma formation. This reaction is a protective mechanism against the cytotoxic secretions from the eggs; however, long-term infections may result in portal hypertension and severe fibrosis of the liver. Although it is possible to detect some pathological features and mild forms of diffuse fibrosis using ultrasonography, it can be difficult, as in many cases there is no apparent sign of disease ([@bib23]). Given the complexity of the liver damage and the variety of measurements, ultrasound readings require expert training in order to correctly determine disease severity and to monitor its progression. In addition, ultrasound can be impractical and expensive as a method of diagnosis and surveillance, particularly at a community level or if used on a large scale.

Previous studies have investigated biochemical markers in serum and plasma to evaluate their efficiency as potential markers of liver damage. Procollagen peptide levels have been shown to be elevated in schistosomiasis patients but drop significantly after praziquantel treatment rendering them ineffectual in monitoring disease progression ([@bib24]). Further, overall sensitivity has been found to be low despite high specificity ([@bib7]). Hyaluronic acid (HA) has shown promising results correlating positively with ultrasound (US) gradings in schistosomiasis japonica ([@bib31; @bib48]) and schistosomiasis mansoni ([@bib27]). In addition, HA levels were not found to be associated with hepatitis infection, thus demonstrating its potential as a marker of fibrosis in patients with co-existing factors of liver inflammation ([@bib12]).

Previously, studies of intestinal schistosomiasis mansoni have implicated sICAM-1 in hepatic inflammation ([@bib41; @bib14; @bib34]) as it is known to play a role in granuloma formation ([@bib37; @bib38]) and in the modulation pathogenesis of hepatic and intestinal schistosomiasis ([@bib22]). In this study, we found the highest levels of sICAM-1 to be amongst acute patients which supports previous findings that elevated expression of sICAM-1 is associated with egg deposition ([@bib22]). Markedly elevated levels of sICAM-I were also observed in advanced schistosomiasis japonica patients diagnosed with periportal fibrosis (grade ⩾ II), a feature previously reported also in hepatic schistosomiasis mansoni ([@bib34]). TNF-alpha is thought to aggravate hepatic schistosomiasis ([@bib21; @bib6]) and can induce shedding of TNF-alpha receptors TNFR-I and TNFR-II ([@bib2; @bib3]). The highly significant correlations of sTNFR-I with sTNFR-II in this study reflect this relationship. Further, high levels of sTNFRs were observed amongst the advanced schistosomiasis japonica patients studied here, implying they could play a key role in the development of hepatic fibrosis. It is noteworthy that the highest levels of these markers were observed in acute patients, thus implicating them in the pro-inflammatory response to granuloma formation and deposition in the liver. Levels of sICAM-1 were also found to significantly correlate with eosinophil counts in acute patients, supporting previous findings that sICAM-1 is crucial in the regulation of eosinophilic inflammation ([@bib45; @bib17]).

SEA-specific levels of IgG4 and total IgG were significantly elevated in all disease groups compared with non-exposed controls. SEA- and SWAP-specific levels of IgG4 and total IgG were the same in chronic and acute schistosomiasis patients but were significantly higher than in the advanced group and thus are indicative of the presence of infection and an active immune response to the parasite. The levels were not significantly different between the acute and chronic patients and thus, though associated with the presence or absence of *S. japonicum* infection, they did not differentiate between the different clinical presentations of schistosomiasis japonica. However, given the high levels of these antibody isotypes in active infection, and the low levels of soluble protein markers observed in chronic patients, the results suggest a clear role for the latter in the granulomatous reaction to egg deposition in acute and advanced patients. The elevated levels of these markers in acute schistosomiasis demonstrate the severity of morbidity in these patients.

We believe this work presents the first investigation of sICAM-1 and sTNFR (I and II) levels in human schistosomiasis japonica and supports findings from previous studies of hepatic schistosomiasis mansoni ([@bib14; @bib34; @bib21; @bib6; @bib9]). In conclusion, there appears to be a strong correlation between sICAM-1, the sTNFRs and disease progression; the elevated levels of all three markers in acute and advanced schistosomiasis patients together reflect an intense inflammatory response. Determination of the levels in serum of sTNFR-II and sICAM-1 may serve as a useful tool for the detection of acute schistosomiasis, and the onset and progression of advanced disease.

This study was supported by a National Health and Medical Research Council of Australia and Wellcome Trust (UK) International Collaborative Research Grants Scheme Award.

![Median soluble fibrosis marker levels (ng/ml) in different *Schistosoma japonicum* clinical disease groups compared with non-exposed controls. Asterisks indicate significant mean differences between each disease group and controls as estimated using Games--Howell post-analysis of variance tests.](gr1){#fig1}

![Antigen-specific IgG4 and total IgG levels in different *Schistosoma japonicum* clinical disease groups compared with non-exposed controls. Serum dilutions were 1:100 and 1:200 for the detection of IgG4 and total IgG levels, respectively. Asterisks indicate significant mean differences between each disease group and controls as estimated using Games--Howell post-analysis of variance tests.](gr2){#fig2}

###### 

Composition and definition of clinically defined schistosomiasis groups and controls

  Disease phase          Number of individuals   Definition                                              Mean age (range)   Sex M/F   Period of water contact   EPG (range)
  ---------------------- ----------------------- ------------------------------------------------------- ------------------ --------- ------------------------- -------------
  Acute                  35                      Documented recent water contact                         19.4               34/1      10.4                      225
                                                 Tested positive for infection by Kato-Katz ([@bib25])   (6--65)                      ±SD 16.3 days             (6--2835)
                                                 Tested positive for infection by serology ([@bib33])                                                           
                                                 Clinical symptoms (fever, and/or other symptoms)                                                               
                                                 Eosinophilia (⩾15% of total leukocyte count)                                                                   
                                                                                                                                                                
  Chronic                45                      Documented history of water contact                     38.1               27/18     3.6                       53
                                                 Tested positive for infection by Kato-Katz              (7--68)                      ±SD 3.7 years             (4--516)
                                                 History of re-infection                                                                                        
                                                 No or mild clinical symptoms                                                                                   
                                                                                                                                                                
  Severe                 34                      Documented history of water contact                     47.1               24/10     N/A                       N/A
                                                 Presence of hypersplenism and portal hypertension       (19--63)                                               
                                                 Splenomegaly (Hackett degree ⩾ II)                                                                             
                                                                                                                                                                
  Non-exposed controls   20                      From non-endemic region                                 39.2               14/6      0                         0
                                                 Tested negative for infection by Kato-Katz              (25--62)                                               
                                                 Healthy during routine check-up                                                                                

N/A, not available; EPG, eggs per gram of faeces.

###### 

Pearson correlation coefficients and two-tailed significances for correlations between markers, infection intensity and eosinophil counts

                         sTNFR-II                                 sICAM-1                                  LnEPG                                    Eosinophil count
  ---------------------- ---------------------------------------- ---------------------------------------- ---------------------------------------- ----------------------------------------
  sTNFR-I                                                                                                                                           
   Pearson correlation   0.723[b](#tblfn2){ref-type="table-fn"}   0.244[b](#tblfn2){ref-type="table-fn"}   0.164                                    −0.013
   Sig. (two-tailed)     0.000                                    0.000                                    0.134                                    0.949
                                                                                                                                                    
  sTNFR-II                                                                                                                                          
   Pearson correlation                                            0.368[b](#tblfn2){ref-type="table-fn"}   0.397[b](#tblfn2){ref-type="table-fn"}   −0.04
   Sig. (two-tailed)                                              0.000                                    0.000                                    0.822
                                                                                                                                                    
  sICAM-1                                                                                                                                           
   Pearson correlation                                                                                     0.355[b](#tblfn2){ref-type="table-fn"}   0.363[a](#tblfn1){ref-type="table-fn"}
   Sig. (two-tailed)                                                                                       0.000                                    0.0442
                                                                                                                                                    
  LnEPG                                                                                                                                             
   Pearson correlation                                                                                                                              0.477[b](#tblfn2){ref-type="table-fn"}
   Sig. (two-tailed)                                                                                                                                0.0072

sTNFR-I, soluble tumour necrosis factor receptor I; sICAM-I, soluble intracellular adhesive molecule; LnEPG, log transformed data for eggs per gram of faeces.

Significant at *P* \< 0.05.

Significant at *P* \< 0.01.
